Form 4 Tracker
Matthew B. Klein

Director, CHIEF EXECUTIVE OFFICER · 3 filings · Latest: Apr 21, 2026

PTC THERAPEUTICS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
PTCT
Klein Matthew B.May 14, 2026
Proposed Sale
$72.462,572$186.4K
PTCT
Klein Matthew B.May 14, 2026
Proposed Sale
$73.0810,000$730.8K
PTCT
Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICERApr 21, 2026
Sale
$70.912,850$202.1K394,070
PTCT
Klein Matthew B.Apr 21, 2026
Proposed Sale
$70.942,850$202.2K
PTCT
Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICERMar 12, 2026
Sale
$64.082,662$170.6K396,920
PTCT
Klein Matthew B.Mar 12, 2026
Proposed Sale
$64.082,662$170.6K
PTCT
Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICERFeb 18, 2026
Sale
$69.367,371$511.3K387,082
PTCT
Klein Matthew B.Feb 18, 2026
Proposed Sale
$69.367,371$511.2K
PTCT
Klein Matthew B.Jan 8, 2026
Proposed Sale
$76.452,514$192.2K
PTCT
Klein Matthew B.Jan 7, 2026
Proposed Sale
$77.483,016$233.7K
PTCT
Klein Matthew B.Jan 6, 2026
Proposed Sale
$76.955,149$396.2K
PTCT
Klein Matthew B.Dec 30, 2025
Proposed Sale
$76.648,089$619.9K
PTCT
Klein Matthew B.Dec 2, 2025
Proposed Sale
$79.073,428$271.1K
PTCT
Klein Matthew B.Aug 5, 2025
Proposed Sale
$51.7410,739$555.7K
PTCT
Klein Matthew B.Apr 22, 2025
Proposed Sale
$48.742,804$136.7K
PTCT
Klein Matthew B.Feb 20, 2025
Proposed Sale
$50.123,895$195.2K
PTCT
Klein Matthew B.Feb 19, 2025
Proposed Sale
$50.103,897$195.2K
PTCT
Klein Matthew B.Jan 8, 2025
Proposed Sale
$44.502,402$106.9K
PTCT
Klein Matthew B.Jan 7, 2025
Proposed Sale
$45.342,142$97.1K
PTCT
Klein Matthew B.Dec 31, 2024
Proposed Sale
$45.168,279$373.9K